Skip to content

Arcutis Biotherapeutics, Inc. ARQT Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Pfizer logo
PfizerPFE
$14.2B+6.8%
Amgen logo
AmgenAMGN
$2.37B+7.0%
Incyte logo
IncyteINCY
$126.59M-27.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$119M-28.3%
Organon logo
OrganonOGN
$984M-1.0%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$17.12M+20.1%

Other financials

Income statement

See full
Revenue$105.4M+60.1%
Gross profit$95.6M+67.7%
Operating income-$9.1M+62.9%
Net income-$11.3M+54.9%
EPS (diluted)-$0.09+55.0%

Balance sheet

See full
Cash & equivalents$35.1M-34.7%
Total debt$114.7M+3.5%
Total equity$189.6M+32.9%
Total assets$460.0M+33.7%

Cash flow

See full
Operating cash flow$2.2M+107%
CapEx--100%
Free cash flow$2.2M+107%

Valuation

See full
Market cap$3.29B+57.5%

Profitability

See full
Gross margin90.9%+2.5pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.6×-0.2×
Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s other non-current liabilities?
Arcutis Biotherapeutics, Inc. (ARQT) reported other non-current liabilities of $431K in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s other non-current liabilities changed year-over-year?
Arcutis Biotherapeutics, Inc.'s other non-current liabilities increased by 19.7% year-over-year, from $360K to $431K.
What is the long-term trend for Arcutis Biotherapeutics, Inc.'s other non-current liabilities?
Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s other non-current liabilities has grown at a 39.4% compound annual growth rate (CAGR), from $82K to $431K.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.